CIK: 0001425738 · Show all filings
Period: Q4 2014 (← Previous) (Next →)
Filing Date: Feb 18, 2015
Total Value ($000): $918,447 (99.8% shares, 0.2% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| FOLD | AMICUS THERAPEUTICS INC | 6,875,274 | $57,202 | 6.2% | $3.25 | +111.2% | COM | 03152W109 |
| — | ARRAY BIOPHARMA INC | 11,858,294 | $56,090 | 6.1% | $4.73 | — | COM | 04269X105 |
| — | VALEANT PHARMACEUTICALS INTL | 338,477 | $48,439 | 5.3% | $131.83 | — | COM | 91911K102 |
| — | CHIMERIX INC | 1,157,184 | $46,588 | 5.1% | $22.91 | — | COM | 16934W106 |
| — | RITE AID CORP | 6,038,734 | $45,411 | 4.9% | $5.77 | — | COM | 767754104 |
| — | CLOVIS ONCOLOGY INC | 721,632 | $40,411 | 4.4% | $37.03 | — | COM | 189464100 |
| — | RECEPTOS INC | 312,736 | $38,313 | 4.2% | $36.95 | — | COM | 756207106 |
| — | CELGENE CORP | 342,349 | $38,295 | 4.2% | $94.78 | — | COM | 151020104 |
| — | AVALANCHE BIOTECHNOLOGIES IN | 699,070 | $37,750 | 4.1% | $30.78 | — | COM | 05337G107 |
| GILD | GILEAD SCIENCES INC | 368,615 | $34,746 | 3.8% | $71.85 | 0.0% | COM | 375558103 |
| — | SEATTLE GENETICS INC | 983,966 | $31,615 | 3.4% | $32.79 | — | COM | 812578102 |
| — | TRIVASCULAR TECHNOLOGIES INC | 1,755,568 | $22,067 | 2.4% | $14.40 | — | COM | 89685A102 |
| — | ZS PHARMA INC | 524,702 | $21,812 | 2.4% | $39.46 | — | COM | 98979G105 |
| — | HEALTHWAYS INC | 1,068,489 | $21,242 | 2.3% | $17.21 | — | COM | 422245100 |
| LAB | FLUIDIGM CORP DEL | 610,442 | $20,590 | 2.2% | $30.66 | -7.6% | COM | 34385P108 |
| AZN | ASTRAZENECA PLC | 258,305 | $18,180 | 2.0% | $70.38 | — | SPONSORED ADR | 046353108 |
| MCK | MCKESSON CORP | 87,523 | $18,168 | 2.0% | $176.84 | +5.7% | COM | 58155Q103 |
| PBYI | PUMA BIOTECHNOLOGY INC | 93,865 | $17,766 | 1.9% | $212.89 | +4.2% | COM | 74587V107 |
| — | NANOSTRING TECHNOLOGIES INC | 1,266,538 | $17,643 | 1.9% | $12.63 | — | COM | 63009R109 |
| — | INTRA CELLULAR THERAPIES INC | 990,810 | $17,488 | 1.9% | $18.07 | — | COM | 46116X101 |
| — | BELLICUM PHARMACEUTICALS INC | 860,809 | $17,269 | 1.9% | $20.06 | — | COM | 079481107 |
| — | NUVASIVE INC | 358,679 | $16,915 | 1.8% | $24.04 | — | COM | 670704105 |
| — | HEALTH NET INC | 309,045 | $16,543 | 1.8% | $46.11 | — | COM | 42222G108 |
| PRQR | PROQR THRAPEUTICS N V | 751,171 | $15,729 | 1.7% | $16.02 | -5.3% | SHS EURO | N71542109 |
| INSM | INSMED INC | 1,012,371 | $15,661 | 1.7% | $15.08 | -5.9% | COM PAR $.01 | 457669307 |
| — | MODEL N INC | 1,461,678 | $15,523 | 1.7% | $10.53 | — | COM | 607525102 |
| UHS | UNIVERSAL HLTH SVCS INC | 135,270 | $15,050 | 1.6% | $83.89 | +19.6% | CL B | 913903100 |
| — | CIVITAS SOLUTIONS INC | 879,485 | $14,978 | 1.6% | $16.04 | — | COM | 17887R102 |
| BIIB | BIOGEN IDEC INC | 43,113 | $14,635 | 1.6% | $323.51 | 0.0% | COM | 09062X103 |
| — | CASTLIGHT HEALTH INC | 1,247,268 | $14,593 | 1.6% | $16.15 | — | CL B | 14862Q100 |
| — | OXFORD IMMUNOTEC GLOBAL PLC | 1,070,995 | $14,587 | 1.6% | $18.17 | — | ORD SHS | G6855A103 |
| GMED | GLOBUS MED INC | 611,731 | $14,541 | 1.6% | $16.20 | +36.6% | CL A | 379577208 |
| ARAY | ACCURAY INC | 1,535,475 | $11,593 | 1.3% | $7.25 | -2.7% | COM | 004397105 |
| — | ACHAOGEN INC | 733,953 | $9,578 | 1.0% | $14.43 | — | COM | 004449104 |
| — | BLUEBIRD BIO INC | 102,227 | $9,376 | 1.0% | $91.72 | — | COM | 09609G100 |
| — | NEVRO CORP | 234,254 | $9,059 | 1.0% | $38.67 | — | COM | 64157F103 |
| — | CONNECTURE INC | 943,000 | $8,496 | 0.9% | $9.01 | — | COM | 20786J106 |
| — | ATARA BIOTHERAPEUTICS INC | 264,266 | $7,069 | 0.8% | $26.75 | — | COM | 046513107 |
| EHTH | EHEALTH INC | 264,942 | $6,602 | 0.7% | $26.31 | -7.6% | COM | 28238P109 |
| — | FLEXION THERAPEUTICS INC | 315,144 | $6,363 | 0.7% | $16.39 | — | COM | 33938J106 |
| — | TOKAI PHARMACEUTICALS INC | 215,139 | $3,171 | 0.3% | $15.14 | — | COM | 88907J107 |
| — | ELEVEN BIOTHERAPEUTICS INC | 240,000 | $2,851 | 0.3% | $11.88 | — | COM | 286221106 |
| — | ARRAY BIOPHARMA INC | 2,000,000 | $1,869 | 0.2% | $0.93 | — | NOTE 3.000% 6/0 | 04269XAA3 |
| PACB | PACIFIC BIOSCIENCES CALIF IN | 237,977 | $1,866 | 0.2% | $6.40 | 0.0% | COM | 69404D108 |
| — | LOXO ONCOLOGY INC | 137,681 | $1,618 | 0.2% | $13.13 | — | COM | 548862101 |
| — | FORWARD PHARMA A/S | 25,235 | $526 | 0.1% | $20.84 | — | SPONSORED ADR | 34986J105 |
| — | CELLDEX THERAPEUTICS INC NEW | 26,100 | $476 | 0.1% | $18.24 | — | COM | 15117B103 |
| — | MARKET VECTORS ETF TR | 6,500 | $418 | 0.0% | $45.08 | — | PHARMACEUTICAL | 57060U217 |
| — | WELLCARE HEALTH PLANS INC | 4,887 | $401 | 0.0% | $60.34 | — | COM | 94946T106 |
| — | POWERSHARES QQQ TRUST | 3,434 | $355 | 0.0% | $103.38 | — | UNIT SER 1 | 73935A104 |
| IBB | ISHARES TR | 1,000 | $303 | 0.0% | $261.30 | — | NASDQ BIOTEC ETF | 464287556 |
| IHF | ISHARES | 2,500 | $296 | 0.0% | $107.04 | — | US HLTHCR PR ETF | 464288828 |
| — | ALEXION PHARMACEUTICALS INC | 1,390 | $257 | 0.0% | $184.89 | — | COM | 015351109 |
| — | SUNESIS PHARMACEUTICALS INC | 25,000 | $64 | 0.0% | $2.56 | — | COM NEW | 867328601 |